During May 11 to 14, 2017, the 23^rd annual meeting of Chinese Society of Dermatology was held in Chongqing, China. The meeting was hosted by Chinese Society of Dermatology.

It is an important academic activity in China’s dermatology science field. YaoPharma has been participating and supporting this event for many years. Through this platform, YaoPharma is dedicated to scientific communications about atopic dermatitis and urticarial. Meanwhile, learn and discuss antihistamine related knowledge and applications with experts participating this event.

————Knowledge————

Kailinzhi from YaoPharma is a highly effective 2^nd generation anti-allergic drug, recommended by multiple medication guides. 

It is used for the prevention and treatment of allergic rhinitis, urticarial, eczema, dermatitis, pruritus of skin, prurigo, psoriasis vulgaris accompanied by itching and allergic bronchial asthma.

It is an anti-allergic drug with the broadest indications approved by CFDA, with unique dosage form in the country. It has the characteristics of quickly alleviating itching, strong anti-allergic effect and low side effects.